Bone-targeted therapy for metastatic breast cancer—Where do we go from here? A commentary from the BONUS 8 meeting

The annual Bone and The Oncologist New Updates (BONUS 8) conference focuses on the current understanding and dilemmas in the treatment and prevention of bone metastasis in cancer, as well as novel research on bone homeostasis and cancer-induced bone loss. We present commentaries from experts for the...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Xiaofu, Amir, Eitan, Singh, Gurmit, Clemons, Mark, Addison, Christina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2014
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4723414/
https://www.ncbi.nlm.nih.gov/pubmed/26909291
http://dx.doi.org/10.1016/j.jbo.2014.01.001
_version_ 1782411507759316992
author Zhu, Xiaofu
Amir, Eitan
Singh, Gurmit
Clemons, Mark
Addison, Christina
author_facet Zhu, Xiaofu
Amir, Eitan
Singh, Gurmit
Clemons, Mark
Addison, Christina
author_sort Zhu, Xiaofu
collection PubMed
description The annual Bone and The Oncologist New Updates (BONUS 8) conference focuses on the current understanding and dilemmas in the treatment and prevention of bone metastasis in cancer, as well as novel research on bone homeostasis and cancer-induced bone loss. We present commentaries from experts for their own take on where they feel the field of bone-targeted therapies for metastatic breast cancer is moving, or needs to move, if we are to make further progress.
format Online
Article
Text
id pubmed-4723414
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-47234142016-02-23 Bone-targeted therapy for metastatic breast cancer—Where do we go from here? A commentary from the BONUS 8 meeting Zhu, Xiaofu Amir, Eitan Singh, Gurmit Clemons, Mark Addison, Christina J Bone Oncol Commentary The annual Bone and The Oncologist New Updates (BONUS 8) conference focuses on the current understanding and dilemmas in the treatment and prevention of bone metastasis in cancer, as well as novel research on bone homeostasis and cancer-induced bone loss. We present commentaries from experts for their own take on where they feel the field of bone-targeted therapies for metastatic breast cancer is moving, or needs to move, if we are to make further progress. Elsevier 2014-02-04 /pmc/articles/PMC4723414/ /pubmed/26909291 http://dx.doi.org/10.1016/j.jbo.2014.01.001 Text en © 2014 Elsevier GmbH. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Commentary
Zhu, Xiaofu
Amir, Eitan
Singh, Gurmit
Clemons, Mark
Addison, Christina
Bone-targeted therapy for metastatic breast cancer—Where do we go from here? A commentary from the BONUS 8 meeting
title Bone-targeted therapy for metastatic breast cancer—Where do we go from here? A commentary from the BONUS 8 meeting
title_full Bone-targeted therapy for metastatic breast cancer—Where do we go from here? A commentary from the BONUS 8 meeting
title_fullStr Bone-targeted therapy for metastatic breast cancer—Where do we go from here? A commentary from the BONUS 8 meeting
title_full_unstemmed Bone-targeted therapy for metastatic breast cancer—Where do we go from here? A commentary from the BONUS 8 meeting
title_short Bone-targeted therapy for metastatic breast cancer—Where do we go from here? A commentary from the BONUS 8 meeting
title_sort bone-targeted therapy for metastatic breast cancer—where do we go from here? a commentary from the bonus 8 meeting
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4723414/
https://www.ncbi.nlm.nih.gov/pubmed/26909291
http://dx.doi.org/10.1016/j.jbo.2014.01.001
work_keys_str_mv AT zhuxiaofu bonetargetedtherapyformetastaticbreastcancerwheredowegofromhereacommentaryfromthebonus8meeting
AT amireitan bonetargetedtherapyformetastaticbreastcancerwheredowegofromhereacommentaryfromthebonus8meeting
AT singhgurmit bonetargetedtherapyformetastaticbreastcancerwheredowegofromhereacommentaryfromthebonus8meeting
AT clemonsmark bonetargetedtherapyformetastaticbreastcancerwheredowegofromhereacommentaryfromthebonus8meeting
AT addisonchristina bonetargetedtherapyformetastaticbreastcancerwheredowegofromhereacommentaryfromthebonus8meeting

Ejemplares similares